After having reviewed a number of blogs which look explicitly at the pharmaceutical industry’s relationship with psychiatry or medical education, I thought it would be interesting to look at a blog that focuses on the more generic aspects of the pharmaceutical industry. The featured blog is the Pharma Blog Review at PharmaLive. This has been going since June 2008, only a little longer than this blog. The emphasis is on looking at developments in the pharmaceutical industry particularly by reviewing other blogs. In one article there is an interesting review of videos posted on YouTube by pharmaceutical companies. For instance, here is a neat video showing the pathophysiology of atherosclerosis. Various articles that are pointed to in the blog include an article about e-prescribing, antidepressants being the most widely sought prescription medications online, a video of Dan Carlat in debate with Tom Stossel, the Flurizan trials in Alzheimer’s Disease, limitations in understanding of G-coupled receptors, the difficulties of establishing an organisation like NICE in the USA and RNAI Therapeutics.
The strength of this blog is that it covers lots of different viewpoints of the pharmaceutical industry and includes for instance coverage of some of the previously featured blogs reviewed in this section. Essentially the reader will be able to get more of an eagle’s eye perspective of events in the world of Pharma and will have a better choice of what issues they want to examine more closely. Reading the pharma blog review can thus be an effective supplementary means of keeping up to date with news in this area.
The comments made here represent the opinions of the author and do not represent the profession or any
body/organisation. The comments made here are not meant as a source of medical advice and those seeking medical advice are advised to consult with their own doctor. The author is not responsible for the contents
of any external sites that are linked to in this blog.